These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 1706986)

  • 1. Long term treatment of duodenal ulcer. A review of management options.
    Bianchi Porro G; Parente F
    Drugs; 1991 Jan; 41(1):38-51. PubMed ID: 1706986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
    Bardhan KD
    Yale J Biol Med; 1996; 69(3):211-24. PubMed ID: 9165690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of duodenal ulcer recurrence.
    Strum WB
    Ann Intern Med; 1986 Nov; 105(5):757-61. PubMed ID: 2876669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Difficult' duodenal ulcer patients: clinical and therapeutic problems.
    Bianchi Porro G; Parente F
    Dig Dis; 1991; 9(4):219-28. PubMed ID: 1680585
    [No Abstract]   [Full Text] [Related]  

  • 5. Intermittent treatment of duodenal ulcer for long term medical management.
    Bardhan KD
    Postgrad Med J; 1988; 64 Suppl 1():40-6. PubMed ID: 2901744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H2-receptor antagonists and duodenal ulcer recurrence: analysis of efficacy and commentary on safety, costs, and patient selection.
    Freston JW
    Am J Gastroenterol; 1987 Dec; 82(12):1242-9. PubMed ID: 2891294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-and cytoprotective drugs in the short-term treatment of peptic ulcer. What is their current role?
    Bianchi Porro G; Parente F
    Ital J Gastroenterol; 1990; 22 Suppl 1():5-10. PubMed ID: 1983422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of resistant duodenal ulcer].
    Vigneri S; Scialabba A; Pisciotta G; Termini R; Muratore F; Vinti M
    Minerva Med; 1989 Nov; 80(11):1205-10. PubMed ID: 2574838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic management of duodenal ulcer except in emergency: eradication of Helicobacter pylori].
    Lamouliatte H
    Gastroenterol Clin Biol; 1996 Jan; 20(1 Pt 2):S58-S63. PubMed ID: 8734372
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevention of duodenal ulcer recurrence. A new prospect].
    Soulé JC
    Presse Med; 1991 Mar; 20(10):465-70. PubMed ID: 1673786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased serum pepsinogen I and recurrence of duodenal ulcer.
    Sumii K; Inbe A; Uemura N; Kimura M; Haruma K; Yoshihara M; Teshima H; Kajiyama G; Miyoshi A
    Scand J Gastroenterol; 1989 Dec; 24(10):1200-4. PubMed ID: 2574906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance treatment with H2 receptor antagonists for duodenal ulcer disease: toward a rational use.
    Kohn A; Annibale B; Delle Fave G; Levenstein S
    Dig Dis; 1993; 11(4-5):228-38. PubMed ID: 7900939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment for gastric and duodenal ulcer.
    Di Mario F; Battaglia G; Pasqualetti P; Vio A; Gottardello L; Grassi SA
    Ital J Gastroenterol; 1990; 22 Suppl 2():24-8. PubMed ID: 1983413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current directions in the treatment of gastric and duodenal ulcers].
    Fellus R
    Dakar Med; 1988; 33(1-4):42-4. PubMed ID: 2908566
    [No Abstract]   [Full Text] [Related]  

  • 15. The influence of relapse rate on the choice of duodenal ulcer therapy.
    Drug Ther Bull; 1987 Oct; 25(20):77-80. PubMed ID: 2890508
    [No Abstract]   [Full Text] [Related]  

  • 16. [Sulglycotide combined with H2-antagonists in the prevention of duodenal ulcer recurrence. Multicenter study].
    Ciaco A; Papi C; Capurso L
    Minerva Gastroenterol Dietol; 1992; 38(3):153-9. PubMed ID: 1363719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [H2 blockers in the treatment of bleeding gastroduodenal ulcers].
    Nikiforov PA; Bazarova MA; Nikitina SA; Osin VL; Shugurov VA
    Khirurgiia (Mosk); 2001; (10):49-50. PubMed ID: 11763821
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of ulcer: a single dose of anti-H2].
    Loizeau E
    Rev Med Suisse Romande; 1985 Apr; 105(4):281-2. PubMed ID: 2861646
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety profile of long-term H2-antagonist therapy.
    Lewis JH
    Aliment Pharmacol Ther; 1991; 5 Suppl 1():49-57. PubMed ID: 1679672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Which drug for peptic ulcer?].
    Hameeteman W; Tytgat GN
    Ned Tijdschr Geneeskd; 1985 Aug; 129(35):1673-6. PubMed ID: 2864643
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.